Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States.
about
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liverReview article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011.PREVALENCE OF BACTERIAL RESISTANCE IN HOSPITALIZED CIRRHOTIC PATIENTS IN SOUTHERN BRAZIL: A NEW CHALLENGE.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Clostridium difficile infection in patients with liver disease: a review.Liver - guardian, modifier and target of sepsis.Time trends in the health care burden and mortality of acute on chronic liver failure in the United States.Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure.Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis.Obesity is independently associated with infection in hospitalised patients with end-stage liver disease.Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review.Scoring systems for 6-month mortality in critically ill cirrhotic patients: a prospective analysis of chronic liver failure - sequential organ failure assessment score (CLIF-SOFA).Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis.Severe periodontitis and higher cirrhosis mortality.Breakthrough Clostridium difficile infection in cirrhotic patients receiving rifaximin.Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort.Outcomes associated with Clostridium difficile infection in patients with chronic liver disease.Rifaximin has the potential to prevent complications of cirrhosisSpontaneous Bacterial Peritonitis in Afebrile Cirrhotic Patients; Report from a Referral Transplantation CenterNoninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms
P2860
Q27001540-2582CF6A-1C64-4DE7-B425-BD7D0D8E1DD6Q34469118-523B3360-0BC6-423E-AEB6-AD0B3170C1FDQ36113668-1E6833B5-1774-46DE-8E14-F6A13B11CACFQ36152842-12F3E82D-F9C4-49AE-9CF0-9E22B1285ED8Q36935021-40E9D51A-6193-48B8-A1D1-6EA5E8DF8F3DQ38524991-D0DD04CD-4C4C-4A2C-ADD2-69F861BF4483Q38600142-35063A20-0369-4A4B-B21F-99ED2B325FF2Q39031051-3C07046D-239D-4E82-8B13-A1542B5A87FCQ39328453-08FD7675-61AC-416C-A73F-89F958FF817CQ40046515-AA09DEA4-47B3-440C-9BA1-7B4BF92B1CC4Q40447189-6FAFC98A-D5A8-4175-82E6-1E17FCE6CE9CQ40933907-9AA6AE18-B321-44D3-88D8-E59FCCD62B4DQ41387562-8ACAD2C8-5678-412A-9EE9-31A320EC508BQ41698366-6663A2EA-A02A-43C4-B930-2B49712445B6Q41744721-3AF08890-10C1-4776-BA24-A52719413118Q47321099-80BB7F62-90DA-48D8-8D72-B02F84C20E7AQ49741756-CA4D1846-B383-44F7-A39A-6F27F953DB27Q50082624-391A2C4A-3982-4A54-BCCB-02668ADC2CC1Q52744422-8A1F824B-1E2C-4091-82DE-AA17B5951254Q54217863-07DF4B0C-3E22-47CC-A921-395B0298A7ACQ57067778-6C26A781-997E-4A68-B4B4-6B3190E3CD37Q58589285-8E111B55-8007-4033-A703-EC7C06D66C11Q59125743-F2BEBA83-BE0A-4805-AAAD-D7F17A92418D
P2860
Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Prevalence and in-hospital mor ...... patients in the United States.
@en
Prevalence and in-hospital mor ...... patients in the United States.
@nl
type
label
Prevalence and in-hospital mor ...... patients in the United States.
@en
Prevalence and in-hospital mor ...... patients in the United States.
@nl
prefLabel
Prevalence and in-hospital mor ...... patients in the United States.
@en
Prevalence and in-hospital mor ...... patients in the United States.
@nl
P2093
P2860
P356
P1476
Prevalence and in-hospital mor ...... patients in the United States.
@en
P2093
P2860
P304
P356
10.1111/APT.12797
P407
P577
2014-05-16T00:00:00Z